Treatment Simplification for People with HIV and Limited Treatment Options: Oral and Long-Acting Approaches
Purpose of Review To examine clinical complexities and emerging therapeutic strategies for people with HIV on complex multi-tablet regimens or with limited treatment options. Recent Findings While single-tablet regimens standardise modern care, 3–10% of individuals face multi-class resistance and complex regimens and have increased risk of potential complications. Newer oral agents and long-acting injectables offer promising pathways to treatment optimisation, reducing pill burden, and overcoming barriers to sustainable access. Summary Transitioning toward person-centred definitions and long-acting or simplified approaches is vital to mitigate chronic inflammation and improve clinical outcomes for heavily treatment-experienced individuals.
Authors
- Chloe M. Orkin (ORCID: https://orcid.org/0000-0001-6168-6745)
- Oliver Mercer
- Kyle Ring (ORCID: https://orcid.org/0000-0003-4016-4643)
Institutions
- Queen Mary University of London (GB)
- Barts Health NHS Trust (GB)
- Royal London Hospital (GB)
- Blizard Institute (GB)
Publication Details
- Journal
- Current HIV/AIDS Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s11904-026-00806-y
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00